Drreddys Laboratories | RDY - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
ANI Pharmaceuticals USD 73.66M 9.14M 2026-03
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Bayer EUR 3.7B 356M 2026-03
Canopy Growth CAD 28.9M 636K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Drreddys Laboratories INR 26.92B 3.74B 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Novartis USD 3.14B 296M 2026-03
Pacira USD 83.88M 7.99M 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 30.28M 606K 2026-03
Richter Gedeon HUF 55.32B 3.03B 2026-03
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Teva Pharmaceutical Industries USD 1000M 120M 2026-03